Literature DB >> 9290467

Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1.

J Hitti1, D H Watts, S K Burchett, T Schacker, S Selke, Z A Brown, L Corey.   

Abstract

OBJECTIVE: Our purpose was to determine whether pregnant women infected with human immunodeficiency virus-1 have an increased risk of herpes simplex virus-2 seropositivity and herpes simplex virus reactivation at delivery. STUDY
DESIGN: Sixty women infected with human immunodeficiency virus and 8408 other patients who were delivered at the University of Washington between 1989 and 1995 had herpes simplex virus serologic determinations at delivery. Genital herpes simplex virus cultures were obtained for 48 (80%) of the human immunodeficiency virus-infected women and 5567 (66%) of the controls. Logistic regression was used to adjust for possible confounding factors.
RESULTS: Forty-five (75%) of human immunodeficiency virus-infected women and 2709 (32%) controls were seropositive for herpes simplex virus-2 (p < 0.0001). Eight percent of human immunodeficiency virus-infected women and 2% of controls had herpes simplex virus reactivation in labor (p < 0.05).
CONCLUSIONS: Infection with herpes simplex virus-2 is common among pregnant women infected with human immunodeficiency virus. Herpes simplex virus reactivation complicates labor in this group more often than in other obstetric patients. The role of herpes simplex virus in perinatal human immunodeficiency virus transmission warrants further study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9290467     DOI: 10.1016/s0002-9378(97)70214-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

2.  Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women.

Authors:  Andrea Lisco; Massimo Barbierato; Josè R Fiore; Paola Gasperini; Anna Favia; Anna Volpe; Maria Chironna; Giuseppe Pastore; Luigi Chieco-Bianchi; Maria Luisa Calabrò
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

Review 3.  A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2.

Authors:  K J Looker; G P Garnett
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

4.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

5.  Changes in immunoglobulin levels related to herpes simplex virus type 1 brain infection in pregnant mice.

Authors:  Javier S Burgos; Carlos Ramirez; Anna Brachet; Juan M Alfaro; Isabel Sastre; Fernando Valdivieso
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

6.  Host factors that influence mother-to-child transmission of HIV-1: genetics, coinfections, behavior and nutrition.

Authors:  Sascha R Ellington; Caroline C King; Athena P Kourtis
Journal:  Future Virol       Date:  2011-11-24       Impact factor: 1.831

7.  Genital HSV detection among HIV-1-infected pregnant women in labor.

Authors:  Janna Patterson; Jane Hitti; Stacy Selke; Meei-Li Huang; D Heather Watts; Zane Brown; Lawrence Corey; Anna Wald
Journal:  Infect Dis Obstet Gynecol       Date:  2011-03-27

8.  Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women.

Authors:  Alison C Roxby; Alison L Drake; Grace John-Stewart; Elizabeth R Brown; Daniel Matemo; Phelgona A Otieno; Carey Farquhar
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

9.  Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial.

Authors:  Alison L Drake; Alison C Roxby; James Kiarie; Barbra A Richardson; Anna Wald; Grace John-Stewart; Carey Farquhar
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

10.  Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.

Authors:  Laith J Abu-Raddad; Amalia S Magaret; Connie Celum; Anna Wald; Ira M Longini; Steven G Self; Lawrence Corey
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.